Vol. 18 No. 3 (2012)

DOI: https://doi.org/10.5912/jcb.v18i3

Published: 2012-06-27

Editorial

Could personalized medicine be the driver for widespread price controls?

Yali Friedman
- PDF

Commentary

Innovating in the New Austerity

G. Steven Burrill
- Requires Subscription PDF (USD 25)

Article

Innovative biotechnology industry strategies in the U.S.â€™ rapidly evolving payer environment

Sarah Stanton Collins, Will Collins
- Requires Subscription PDF (USD 25)
Biotechnology in Argentina: Development and Resources

Claudia Zylberberg, Asli Ceylan Oner, Ezequiel Zylberberg
- Requires Subscription PDF (USD 25)

Case Study

Creating systemic oral transmucosal drug delivery strategies: Case study of APL-130277

Anthony Giovinazzo, Nathan Bryson, Timothy Tankosic
- Requires Subscription PDF (USD 25)
What do hospital labs really need to streamline diagnostic testing: Apple vs. Microsoft environment?

Doug Millar, John Melki
- PDF

From the Classroom

A general model for training the next generation of Biotechnology entrepreneurs based on recent experience of USA-UK-South Africa collaborations

Karl J. Kunert, Blessed Okole, Barend J. Vorster, Nicholas J. Brewin, Christopher A. Cullis
- Requires Subscription PDF (USD 25)

From the Boardroom

Biomarketing strategy and tactics 101 PART II of III

Dimitris Dogramatzis
- Requires Subscription PDF (USD 25)
Disaster Planning for Biotechnology Companies

Frank Goudsmit
- Requires Subscription PDF (USD 25)

Legal and Regulatory Updates

Are laboratory notebooks necessary in a first inventor to file world?

Deborah L. Lu, Thomas Kowalski, Smitha Uthaman
- Requires Subscription PDF (USD 25)
Mayo â€œnaysâ€: The Supreme Court says no to patenting laws of nature

Jennifer A. Camacho
- Requires Subscription PDF (USD 25)
EU Legal & Regulatory Update

Ewan Grist
- Requires Subscription PDF (USD 25)

Conference Report

Drug discovery & Development Landscape: New Trends in Academia-Industry Partnerships

Vasu Pestonjamasp
- Requires Subscription PDF (USD 25)